One year follow-up study of healthy adults who received one injection of live attenuated varicella vaccine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080223928

Enrollment

Registered

2018-06-01

Start date

2018-06-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

protection against Herpes Zoster

Interventions

investigational material(s) Generic name etc : Oka/Biken live attenuated varicella zoster vaccine INN of investigational material : Freeze-dried Live Attenuated Varicella Vaccine Therapeutic category

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: volunteers who participated in previous VZV vaccine study (JAPIC CTI-173532)

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
exploratory Flowcytometric analyses of VZV CD4 memory cell response	—

Secondary

Measure	Time frame
confirmatory Confirming the state of VZV specific antibody using EIA	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026